Erin St. Onge

741 total citations
38 papers, 534 citations indexed

About

Erin St. Onge is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pharmacology. According to data from OpenAlex, Erin St. Onge has authored 38 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in Erin St. Onge's work include Diabetes Treatment and Management (10 papers), Diabetes Management and Research (7 papers) and Pharmacology and Obesity Treatment (6 papers). Erin St. Onge is often cited by papers focused on Diabetes Treatment and Management (10 papers), Diabetes Management and Research (7 papers) and Pharmacology and Obesity Treatment (6 papers). Erin St. Onge collaborates with scholars based in United States. Erin St. Onge's co-authors include Shannon Miller, Karen Whalen, Éric Meyer, Fulton T. Crews, Kenneth C. Jackson, Carol Motycka, William C. Mobley, Jennifer S. Williams, Elizabeth Clements and James R. Taylor and has published in prestigious journals such as Neurobiology of Aging, Neurochemical Research and Clinical Therapeutics.

In The Last Decade

Erin St. Onge

36 papers receiving 515 citations

Peers

Erin St. Onge

EDM

SURGE

CMN

PHARM

Laura Ribeiro Portugal

Simon H. Ridley United Kingdom

Eleanor Clune Australia

Shunji Yamazaki Japan

Ruth Huh United States

B Astruc France

Lael Reinstatler United States

Chi Kin Wong Canada

Yasushi Okuno Japan

Jadranka Sertić Croatia

Laura Ribeiro Portugal

Erin St. Onge

90 ×0.4

EDM

137 ×0.9

75 ×0.7

SURGE

77 ×0.8

CMN

58 ×0.7

PHARM

Citations per year, relative to Erin St. Onge Erin St. Onge (= 1×) peers Laura Ribeiro

Countries citing papers authored by Erin St. Onge

Since Specialization

Citations

This map shows the geographic impact of Erin St. Onge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin St. Onge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin St. Onge more than expected).

Fields of papers citing papers by Erin St. Onge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin St. Onge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin St. Onge. The network helps show where Erin St. Onge may publish in the future.

Co-authorship network of co-authors of Erin St. Onge

This figure shows the co-authorship network connecting the top 25 collaborators of Erin St. Onge. A scholar is included among the top collaborators of Erin St. Onge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin St. Onge. Erin St. Onge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Onge, Erin St., et al.. (2024). Pressing Update: Aprocitentan for the Treatment of Hypertension. Annals of Pharmacotherapy. 59(4). 364–370.

Taylor, James R., et al.. (2024). Implementation of standard setting for high-stakes objective structured clinical examinations. Currents in Pharmacy Teaching and Learning. 16(6). 465–468. 2 indexed citations

Miller, Stacy, Erin St. Onge, Shauna M. Buring, et al.. (2023). Curricular changes in times of crisis: Lessons learned. Currents in Pharmacy Teaching and Learning. 15(1). 101–109.

Miller, Shannon, Erin St. Onge, & Karen Whalen. (2020). Romosozumab: A Novel Agent in the Treatment for Postmenopausal Osteoporosis. Journal of Pharmacy Technology. 37(1). 45–52. 27 indexed citations

Miller, Shannon, et al.. (2019). Ambulatory care elective: Introduction to core practice concepts. Currents in Pharmacy Teaching and Learning. 12(3). 331–338. 4 indexed citations

Onge, Erin St., et al.. (2019). Exploring the Differences between Hispanic Men and Women with Type 2 Diabetes Mellitus Using the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Food and Nutrition Sciences. 10(7). 713–718. 2 indexed citations

Onge, Erin St., et al.. (2017). The role of glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes. Journal of Translational Internal Medicine. 5(2). 79–89. 7 indexed citations

Whalen, Karen, Shannon Miller, & Erin St. Onge. (2015). The Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Treatment of Type 2 Diabetes. Clinical Therapeutics. 37(6). 1150–1166. 71 indexed citations

Onge, Erin St., et al.. (2015). A Review of the Treatment of Type 2 Diabetes in Children. The Journal of Pediatric Pharmacology and Therapeutics. 20(1). 4–16. 33 indexed citations

10.

Motycka, Carol, Erin St. Onge, & Jennifer S. Williams. (2013). Asynchronous Versus Synchronous Learning in Pharmacy Education. Journal of Curriculum and Teaching. 2(1). 16 indexed citations

11.

Onge, Erin St., Shannon Miller, & Elizabeth Clements. (2012). Sitagliptin/Metformin (janumet) as combination therapy in the treatment of type-2 diabetes mellitus.. PubMed. 37(12). 699–708. 12 indexed citations

12.

Onge, Erin St., Katie J. Suda, Leslie L. Devaud, et al.. (2012). Approaches to management of dilemmas by leaders in academic pharmacy. Currents in Pharmacy Teaching and Learning. 4(2). 78–83.e2. 2 indexed citations

13.

Williams, Jennifer S., Carol Motycka, & Erin St. Onge. (2011). Redesign of a Pediatric Pharmacotherapy Elective Course to Accommodate Budget Reductions. American Journal of Pharmaceutical Education. 75(10). 206–206. 3 indexed citations

14.

Miller, Shannon & Erin St. Onge. (2011). Otelixizumab: a novel agent for the prevention of type 1 diabetes mellitus. Expert Opinion on Biological Therapy. 11(11). 1525–1532. 6 indexed citations

15.

Whalen, Karen & Erin St. Onge. (2010). Saxagliptin (Onglyza) for Type 2 Diabetes Mellitus. American family physician. 81(12). 1483. 1 indexed citations

16.

Onge, Erin St. & Shannon Miller. (2010). Albiglutide: a new GLP-1 analog for the treatment of type 2 diabetes. Expert Opinion on Biological Therapy. 10(5). 801–806. 45 indexed citations

17.

Miller, Shannon, et al.. (2008). Angiotensin II vaccine: a novel approach in the treatment of hypertension. Expert Opinion on Biological Therapy. 8(11). 1669–1673. 5 indexed citations

18.

Onge, Erin St. & Shannon Miller. (2008). Pain associated with diabetic peripheral neuropathy: a review of available treatments.. PubMed. 33(3). 166–76. 11 indexed citations

19.

Miller, Shannon & Erin St. Onge. (2006). Sitagliptin: A Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes. Annals of Pharmacotherapy. 40(7-8). 1336–1343. 81 indexed citations

20.

Jackson, Kenneth C. & Erin St. Onge. (2003). Antidepressant Pharmacotherapy: Considerations for the Pain Clinician. Pain Practice. 3(2). 135–143. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact